Cited by 95Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration MechanismsNeuroscience and Neuropharmacology Research

Allopregnanolone and neuroinflammation: a focus on multiple sclerosis

Open access
Noorbakhsh, Farshid, Baker, Glen B., Power, Christopher·2014·Frontiers in Cellular Neuroscience

Abstract

The progesterone derivative allopregnanolone (ALLO) is one of the most widely studied compounds among neurosteroids. Through interactions with GABA-A receptors expressed by neurons and glial cells, ALLO has been shown to affect diverse aspects of neural cell physiology, including cell proliferation and survival, migration, and gene expression. Recent data point to important roles for ALLO in different neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis (MS). Dysregulation in ALLO biosynthesis pathways has been reported in brain tissue from MS patients as well as in the central nervous system (CNS) tissue derived from MS animal models. Administration of ALLO has been shown to ameliorate neurobehavioral deficits together with neuropathology and inflammation in the CNS of animals with autoimmune demyelination. These findings are in line with previous reports indicating growth- and differentiation-promoting actions of ALLO on neurons and glial cells as well as its neuroprotective effects in the context of other CNS diseases. Nonetheless, these findings have also raised the possibility that ALLO might influence leukocyte biology and associated neuroinflammatory mechanisms independent of its neuroregenerative properties. Herein, we review the current knowledge regarding the role of ALLO in the pathogenesis of MS, and discuss the potential cellular and molecular pathways that might be influenced by ALLO in the context of disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fncel.2014.00134

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Allopregnanolone is beneficial for type C Niemann-Pick disease, Alzheimer's disease, and multiple sclerosis based on preclinical studies in animal models.

    “Allopregnanolone is beneficial for type C Niemann-Pick disease, AD, and MS based on preclinical studies in animal models (443).”

    From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [443]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

4 of the 76 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Noorbakhsh, F., Baker, G. B., & Power, C.
Affiliations
  • Tehran University of Medical Sciences (IR)
  • University of Alberta (CA)
Corresponding author
Noorbakhsh, Farshid
Venue
Frontiers in Cellular Neuroscience
Published
2014-06-03
Volume
8
Pages
134-134
ISSN
1662-5102 (ISSN-L)
OpenAlex
W2115574860
Cited by
95
References
76
Citations by year
2026: 5 · 2025: 11 · 2024: 7 · 2023: 4 · 2022: 11 · 2021: 9 · 2020: 10 · 2019: 8 · 2018: 7 · 2017: 3 · 2016: 9 · 2015: 10 · 2014: 1
FWCI
1.09
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Frontiers in Cellular Neuroscience (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Multiple Sclerosis Society of Canada
  • Multiple Sclerosis Society
  • Alberta Innovates
  • Canadian Institutes of Health Research
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
allopregnanolone, neuroinflammation, multiple sclerosis, neurosteroids, GABAA receptor, neuroprotection, autoimmune demyelination, leukocyte biology, neurodegenerative diseases, neurosteroidogenesis, glial cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review